NIH-funded research R15 grant

Using zinc to protect the heart from damage during blood flow restoration

Official title: Zinc Protection Against Ischemia-Reperfusion Injury in Heart

Funded at University of Texas Arlington · NIH-10652915 · Data updated 2026-11-12

This study is looking at how zinc might help protect your heart from damage when blood flow is restored after being blocked, and it aims to find a safe way to deliver zinc to heart cells while understanding how certain genes can help with this process.

Quick facts

Grant typeR15 grant
Study typeNIH-funded research
Funding institutionUniversity of Texas Arlington
NIH-funded
Lab location1 site (Arlington, United States)
Project startJuly 1, 2023
Project endJune 30, 2026
Funding year2023
Award (this year)$443,022
NIH project number1R15HL168628-01
Project IDNIH-10652915 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals at risk of ischemia-reperfusion injury, such as those with cardiovascular diseases.

Less likely to help

Patients who do not have cardiovascular issues or are not at risk of ischemia-reperfusion injury may not benefit from this research.

What this research studies

This research investigates how zinc can be used to protect the heart from injury caused by the restoration of blood flow after a period of reduced blood supply, known as ischemia-reperfusion injury. The study aims to find a safe and effective way to deliver zinc to heart cells without causing harmful side effects. Researchers will explore the role of specific genes in regulating zinc uptake in heart muscle cells and how enhancing these genes might help prevent damage during blood flow restoration. The ultimate goal is to develop a therapeutic approach that could lead to clinical trials for heart protection.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that significantly reduce heart damage during critical medical situations like heart attacks.

How similar studies have gone: Previous research has shown promise in using antioxidants for heart protection, but the specific approach of using zinc in this manner is relatively novel.

Where this research is happening

  • University of Texas Arlington
    Arlington, United States
    Active

Researchers

  • Principal investigator: Pan, Zui — University of Texas Arlington
  • Study coordinator: Pan, Zui

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.